In the ulcerated tumor, B cells showed increased markers associated with type-2 responses such as CCL17, IL4R, and decreases in interferon-stimulated genes (IFI44L, STAT1, IFITM1, MX1, IRF1, Fig. 7 D, Table S12). This evidence concerns the gene CCL17 and neoplasm.